Congenital Hyperinsulinism Treatment Market is Estimated To Witness High Growth Owing To Increasing New Born Screening Testing
by The Congenital Hyperinsulinism Treatment Market is estimated to be valued at US$ 217.74 Mn in 2023 and is expected to exhibit a CAGR of 5.7% …